Secretropin is the first clinically proven  natural stimulator of growth hormone production, and is gaining the  medical community's acceptance as a more desirable "first step" approach  to pursuing hormonal balance.   

Developed in 2001, the product virtually sat on the shelf due to the availability of recombinant human growth hormone (rhGH). Between 2001 and 2006, the product was sold quietly to patients that preferred not to pay the high price of rhGH. Secretropin received early medical  acknowledgment for its reproducible effectiveness and its preferable  oral delivery. In as little as 4 weeks Secretropin has been shown to  increase the production of human growth hormone by 50 - 200% while being  delivered as an oral spray. Secretropin's oral delivery system owes its  effectiveness to the latest nanoliposomal technology, which wraps the  active agents in a protective envelope. Until this delivery technology  was available, stomach acid would inactivate and destroy the active  agents responsible for the increase in growth hormone production. 

  
Prior to Secretropin, the injectable growth hormone was the only viable  option for increasing human growth hormone. Fortunately, the  nanoliposomal technology protects the complex, allowing for optimal  absorption and leading to a more natural increase in growth hormone  levels—thus eliminating the less desirable approach of daily injections.

   
In October 2006, an initial study group of 50 individuals was employed for a prospective, 12-month study on the product's efficacy on increasing IGF-1 and IGFBP-3 levels. As this study approached completion in January 2008, a subsequent study design was begun to include multiple centers for a continued long term assessment of the product's efficacy. We anticipate employing hundreds of new patients. It is the goal of these studies to constantly show the efficacy and related benefits from an amino acid complex growth hormone stimulator.